Search

everythinglearnresearchcommunity

for

Search:↓

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Estrogen therapy can reduce skin aging but has cancer risks.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Women with excessive hair growth often have hormonal issues and need medical advice and treatment.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Hair loss can occur as a side effect of certain breast cancer treatments, but minoxidil can help regrow hair.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Finasteride effectively stops hair loss in most patients, but concerns about rare sexual side effects exist.

Erosive pustular dermatosis in elderly people may be linked to aging immune systems and skin damage.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Improving blood flow and oxygen levels in middle age may help prevent age-related diseases.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Testosterone's effects on COVID-19 are unclear and need more research.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.